Literature DB >> 7897169

Influenza and pneumococcal vaccination and tuberculin skin testing programs in long-term care facilities: where do we stand?

M A McArthur1, A E Simor, B Campbell, A McGeer.   

Abstract

OBJECTIVE: 1) To compare policies and procedures for distribution of influenza and pneumococcal vaccines to long-term care facilities for the elderly in Canada, 2) to determine vaccination rates of residents and staff, and 3) to describe vaccination and tuberculin skin testing programs in these facilities.
DESIGN: A cross-sectional survey consisting of telephone interviews and a mailed questionnaire was conducted in the spring of 1991. Telephone interviews were conducted with provincial/territorial epidemiologists. The questionnaire was sent to all (N = 1.520) Canadian long-term care facilities for the elderly with > or = 25 beds.
RESULTS: There were 1,270 responding facilities (84%). The mean overall influenza vaccination rate for residents was 78.5%. The mean vaccination rate was higher in those provinces in which the vaccine was paid for by the government (79% versus 71%; P = 0.002). Only 19% of facilities reported staff vaccination rates > 25%; rates again were higher in those provinces in which vaccine for staff was provided by the government. Pneumococcal vaccine was offered to residents in 12% of the facilities. The proportions of facilities with > 10% and > 75% of residents vaccinated were significantly higher in the provinces where the pneumococcal vaccine was recommended and paid for as compared with those where it was not (P < 0.001 for both). Tuberculin skin testing programs for residents existed in 360 long-term care facilities (28%) across the country.
CONCLUSION: In 1990, the number of residents living in Canadian long-term care facilities who were vaccinated against influenza and Streptococcus pneumoniae was suboptimal. Staff influenza vaccination rates were very low across the country. Most facilities did not have a baseline tuberculin skin test status for their residents. Vaccination rates are higher in jurisdictions in which governments provide the vaccine without charge.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7897169     DOI: 10.1086/646997

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  6 in total

1.  Influenza vaccination in Alberta long-term care facilities.

Authors:  M L Russell
Journal:  CMAJ       Date:  2001-05-15       Impact factor: 8.262

2.  Preventing influenza outbreaks in long-term care facilities.

Authors:  S E Tamblyn
Journal:  CMAJ       Date:  1997-10-01       Impact factor: 8.262

3.  Statement on Seasonal Trivalent Inactivated Influenza Vaccine (TIV) for 2010-2011: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Authors: 
Journal:  Can Commun Dis Rep       Date:  2010-08-31

4.  Prevention of influenza and pneumococcal pneumonia in Canadian long-term care facilities: how are we doing?

Authors:  C G Stevenson; M A McArthur; M Naus; E Abraham; A J McGeer
Journal:  CMAJ       Date:  2001-05-15       Impact factor: 8.262

5.  Influenza and pneumococcal vaccination in long term care facilities in two regions of Quebec.

Authors:  P De Wals; M Carbonneau; H Payette; T Niyonsenga
Journal:  Can J Infect Dis       Date:  1996-09

6.  Vaccination practices of Quebec family physicians. Influenza vaccination status and professional practices for influenza vaccination.

Authors:  G Baron; P De Wals; F Milord
Journal:  Can Fam Physician       Date:  2001-11       Impact factor: 3.275

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.